Association between the CD14-260C>T gene polymorphism and susceptibility to myocardial infarction: Evidence from case-control studies
- PMID: 31183977
- DOI: 10.1111/iji.12445
Association between the CD14-260C>T gene polymorphism and susceptibility to myocardial infarction: Evidence from case-control studies
Abstract
Numerous published studies have investigated the relationship between the CD14-260C>T (rs2569190) polymorphism and the risk of myocardial infarction (MI). However, the results are still conflicting and inconclusive. Potentially eligible published articles were searched in four databases including PubMed, Web of Science, EMBASE and Chinese Biomedical Database (CBM). The odds ratio (OR) with its 95% confidence interval (CI) was used to estimate the strength of the associations. Thirteen papers including 17 case-control studies were included, reporting a total of 6,443 MI patients and 6,315 controls. A significant increase in overall MI susceptibility was identified in the homozygote model. In the subgroup analysis, with respect to the type of MI, a significantly increasing acute MI susceptibility was found in the homozygote model. In the subgroup analysis for ethnicity, a significant increased susceptibility was found in Asian populations in allele, homozygote, recessive and dominant models. However, no significant association was found among Caucasian populations. In conclusion, there may be a moderate association between the CD14-260C>T polymorphism and acute MI susceptibility. This association may be different between ethnicities with the CD14-260C>T polymorphism being a risk factor for myocardial infarction in Asian populations.
Keywords: CD14; meta-analysis; myocardial infarction; polymorphism; susceptibility.
© 2019 John Wiley & Sons Ltd.
Similar articles
-
Association between the -159C/T polymorphism in the promoter region of the CD14 gene and sepsis: a meta-analysis.BMC Anesthesiol. 2017 Jan 25;17(1):11. doi: 10.1186/s12871-017-0303-9. BMC Anesthesiol. 2017. PMID: 28122493 Free PMC article.
-
The association between CD14-260C/T polymorphism and malignant tumor risk: a meta-analysis of 5,603 participants.Tumour Biol. 2014 Sep;35(9):8707-13. doi: 10.1007/s13277-014-2040-8. Epub 2014 May 29. Tumour Biol. 2014. PMID: 24870592
-
Associations of CD14 variants with the triglyceride levels and risk of myocardial infarction in an Eastern Chinese Han population.Int Immunopharmacol. 2021 Oct;99:108041. doi: 10.1016/j.intimp.2021.108041. Epub 2021 Aug 11. Int Immunopharmacol. 2021. PMID: 34435580
-
CD14 C-260T gene polymorphism and ischemic heart disease susceptibility: a HuGE review and meta-analysis.Genet Med. 2009 Jun;11(6):403-8. doi: 10.1097/GIM.0b013e3181a16cb0. Genet Med. 2009. PMID: 19346955 Review.
-
Association of CD14-260 (-159) C/T and Alzheimer's disease: systematic review and trial sequential analyses.J Neural Transm (Vienna). 2018 Sep;125(9):1313-1318. doi: 10.1007/s00702-018-1896-y. Epub 2018 Jun 20. J Neural Transm (Vienna). 2018. PMID: 29926267
Cited by
-
The Effects of Hypoxic Preconditioned Murine Mesenchymal Stem Cells on Post-Infarct Arrhythmias in the Mouse Model.Int J Mol Sci. 2022 Aug 9;23(16):8843. doi: 10.3390/ijms23168843. Int J Mol Sci. 2022. PMID: 36012110 Free PMC article.
References
REFERENCES
-
- Danesh, J., Collins, R., & Peto, R. (1997). Chronic infections and coronary heart disease: Is there a link? The Lancet, 350, 430-436. https://doi.org/10.1016/S0140-6736(97)03079-1
-
- Dod, H. S., Bhardwaj, R., Sajja, V., Weidner, G., Hobbs, G. R., Konat, G. W., … Jain, A. C. (2010). Effect of intensive lifestyle changes on endothelial function and on inflammatory markers of atherosclerosis. The American Journal of Cardiology, 105, 362-367. https://doi.org/10.1016/j.amjcard.2009.09.038
-
- Epstein, F. H., Fuster, V., Badimon, L., Badimon, J. J., & Chesebro, J. H. (1992). The pathogenesis of coronary artery disease and the acute coronary syndromes (1). New England Journal of Medicine, 326, 242-250. https://doi.org/10.1056/NEJM199201233260406
-
- Forrester, J. S. (2000). Role of plaque rupture in acute coronary syndromes. The American Journal of Cardiology, 86, 15J-23J. https://doi.org/10.1016/S0002-9149(00)01195-4
-
- Haberbosch, W., Unkelbach, K., Schuster, D., Gardemann, A., Tillmanns, H., & Holschermann, H. (2009). CD14 promoter polymorphism (- 159C->t) is not associated with myocardial infarction or coronary artery disease in patients with assumed high genetic risk. The Thoracic and Cardiovascular Surgeon, 57, 386-390.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials